Strasbourg (France), Tokyo (Japan) and Waltham, Mass, Mar 5, 2024 – (JCN Newswire) – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, NEC Corporation (TSE: 6701), a leader in IT, network and AI technologies and BostonGene Corporation (BostonGene…
Read More
